Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco Trevisani

Showing results (141-150 of 208) with videos related to

Pageof 21
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 21, 2011
Changing aetiological factors of hepatocellular carcinoma and their potential impact on the effectiveness of surveillanceTommaso Stroffolini, Franco Trevisani, Giovanbattista Pinzello, et al.
The Lancet. Oncology|July 6, 2023
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy conceptAlessandro Vitale, Giuseppe Cabibbo, Massimo Iavarone, et al.
Cancers|November 2, 2019
Overview of Immune Checkpoint Inhibitors Therapy for Hepatocellular Carcinoma, and The ITA.LI.CA Cohort Derived Estimate of Amenability Rate to Immune Checkpoint Inhibitors in Clinical PracticeEdoardo G Giannini, Andrea Aglitti, Mauro Borzio, et al.
Journal of Hepatology|July 16, 2011
The changing scenario of hepatocellular carcinoma over the last two decades in ItalyValentina Santi, Daniela Buccione, Antonio Di Micoli, et al.
Liver Cancer|March 12, 2021
Clinical-Radiomic Analysis for Pretreatment Prediction of Objective Response to First Transarterial Chemoembolization in Hepatocellular CarcinomaMingyu Chen, Jiasheng Cao, Jiahao Hu, et al.
The Lancet. Oncology|June 21, 2011
Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort studyAlessandro Vitale, Rafael Ramirez Morales, Giacomo Zanus, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 18, 2013
Position paper of the Italian Association for the Study of the Liver (AISF): the multidisciplinary clinical approach to hepatocellular carcinoma, , , et al.
Gut|March 9, 2010
Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20-year multicentre experienceFederica Mirici-Cappa, Annagiulia Gramenzi, Valentina Santi, et al.
Cancer|April 12, 2014
Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical useEdoardo G Giannini, Giorgio Sammito, Fabio Farinati, et al.
Open Forum Infectious Diseases|November 19, 2020
Prognostic Role of Bacterial and Fungal Infections in Patients With Liver Cirrhosis With and Without Acute-on-Chronic Liver Failure: A Prospective 2-Center StudyMichele Bartoletti, Maurizio Baldassarre, Marco Domenicali, et al.
Pageof 21

Showing results (141-150 of 208) with videos related to

Sort By:
Pageof 21
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 21, 2011
Changing aetiological factors of hepatocellular carcinoma and their potential impact on the effectiveness of surveillanceTommaso Stroffolini, Franco Trevisani, Giovanbattista Pinzello, et al.
The Lancet. Oncology|July 6, 2023
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy conceptAlessandro Vitale, Giuseppe Cabibbo, Massimo Iavarone, et al.
Cancers|November 2, 2019
Overview of Immune Checkpoint Inhibitors Therapy for Hepatocellular Carcinoma, and The ITA.LI.CA Cohort Derived Estimate of Amenability Rate to Immune Checkpoint Inhibitors in Clinical PracticeEdoardo G Giannini, Andrea Aglitti, Mauro Borzio, et al.
Journal of Hepatology|July 16, 2011
The changing scenario of hepatocellular carcinoma over the last two decades in ItalyValentina Santi, Daniela Buccione, Antonio Di Micoli, et al.
Liver Cancer|March 12, 2021
Clinical-Radiomic Analysis for Pretreatment Prediction of Objective Response to First Transarterial Chemoembolization in Hepatocellular CarcinomaMingyu Chen, Jiasheng Cao, Jiahao Hu, et al.
The Lancet. Oncology|June 21, 2011
Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort studyAlessandro Vitale, Rafael Ramirez Morales, Giacomo Zanus, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 18, 2013
Position paper of the Italian Association for the Study of the Liver (AISF): the multidisciplinary clinical approach to hepatocellular carcinoma, , , et al.
Gut|March 9, 2010
Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20-year multicentre experienceFederica Mirici-Cappa, Annagiulia Gramenzi, Valentina Santi, et al.
Cancer|April 12, 2014
Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical useEdoardo G Giannini, Giorgio Sammito, Fabio Farinati, et al.
Open Forum Infectious Diseases|November 19, 2020
Prognostic Role of Bacterial and Fungal Infections in Patients With Liver Cirrhosis With and Without Acute-on-Chronic Liver Failure: A Prospective 2-Center StudyMichele Bartoletti, Maurizio Baldassarre, Marco Domenicali, et al.
Pageof 21